Antimicrobial resistance to benzylpenicillin in invasive pneumococcal disease in Belgium, 2003-2010: The effect of altering clinical breakpoints

Epidemiology and Infection

Volumn 141, Issue 3, 2013, Pages 490-495

  Goossens, M C ^a   Catry, B ^a   Verhaegen, J ^b  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Antibiotic resistance; clinical microbiology; Streptococcus pneumoniae (pneumococcus); surveillance system

Indexed keywords

PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BELGIUM; NONHUMAN; PNEUMOCOCCAL INFECTION; QUANTITATIVE ANALYSIS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BELGIUM; DRUG RESISTANCE, BACTERIAL; EPIDEMIOLOGICAL MONITORING; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLIN G; PNEUMOCOCCAL INFECTIONS; PRACTICE GUIDELINES AS TOPIC; STREPTOCOCCUS PNEUMONIAE;

EID: 84876937513     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268812001057     Document Type: Article

References (10)

1. Van Kerkhoven D, et al. Breakthrough pneumococcal bacteraemia in patients treated with clarithromycin or oral beta-lactams. Journal of Antimicrobial Chemotherapy 2003; 51: 691-696.
2. European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2010. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). Stockholm: ECDC, 2011.
3. Marshall KJ, et al. Testing of Streptococcus pneumoniae for resistance to penicillin. Journal of Clinical Microbiology 1993; 31: 1246-1250.
4. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 15th informational supplement M100-S15. Wayne, PA: CLSI, 2005.
5. Masiero G, et al. Socioeconomic determinants of outpatient antibiotic use in Europe. International Journal of Public Health 2010; 55: 469-478.
6. Karlsson D. Probabilistic network modelling of the impact of penicillin consumption on spread of pneumococci. Epidemiology and Infection 2011; 139: 1351-1360.
7. Pletz MW, et al. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. International Journal of Antimicrobial Agents 2008; 32: 199-206.
8. Centers for Disease Control and Prevention. Effects of new penicillin susceptibility breakpoints for Streptococcus pneumoniae. Morbidity and Mortality Weekly Report 2008; 57: 1353-1355.
9. Weinstein MP, Klugman KP, Jones RN. Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance. Clinical Infectious Diseases 2009; 48: 1596-1600.
10. Drlica K, Perlin DS. Antibiotic Resistance: Understanding and Responding to an Emerging Crisis. New Jersey, USA: FT Press, 2011, pp. 55-71.